Analyst Ratings for Maravai LifeScience Holdings Inc. (MRVI)
MRVI Rating Summary
MRVI Price Target Summary
- Highest: $8.00 (UBS)
- Lowest: $3.00 (Baird)
- Average: $5.38
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$5.38 (-20.8%)
* Over Last 12-Mos
Rating Score: 4.7 / 10
Percentile Rank: 47%
Avg. $ Target:
$5.38 (-20.8%)
* Over Last 12-Mos
Rating Score: 4.7 / 10
Percentile Rank: 47%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/5/2026 | TD Cowen | Brendan Smith | New Coverage | Buy (N/A) |
N/A (N/A) |
7.90 (6.79) |
-14.05% | Details |
| 2/26/2025 | Baird » Updated 2/26/2026 |
Catherine Schulte | Downgrade | Neutral (Outperform) |
3.00 (2.00) |
4.01 (6.79) |
69.33% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
